TABLE 3.
Respondents’ beliefs and knowledge regarding Lyme disease (LD)
| Yes | No | Don’t know | |
|---|---|---|---|
| Believed a patient could contract LD in his practice region | |||
| Montérégie | 113 (78) | 10 (7) | 21 (15) |
| Other regions | 25 (53) | 13 (28) | 9 (19) |
| Total | 138 (72) | 23 (12) | 30 (16) |
| Knew LD-endemic areas in the United States | 129 (66) | 47 (24) | 18 (9) |
| Knew LD-endemic areas in Canada | 101 (52) | 64 (33) | 31 (16) |
| Knew LD-endemic areas in Europe | 18 (10) | 109 (59) | 57 (31) |
| Recognized characteristics that define erythema migrans (bull’s-eye lesion, expanding lesion [≥5 cm], occurs in 60% to 80% of cases, no pain) | 80 (40) | 67 (34) | 52 (26) |
| Believed that tick identification and tick testing for Borrelia burgdorferi is a decision tool for LD diagnosis | 133 (69) | 28 (14)* | 33 (17) |
| Believed that tick identification and tick testing for B burgdorferi is used to identify LD risk zones in Quebec | 173 (88)* | 3 (2) | 21 (11) |
| Recognized early signs and symptoms related to early stage LD | |||
| Fever | 131 (75)* | 21 (12) | 22 (13) |
| Erythema migrans | 169 (91)* | 7 (4) | 10 (5) |
| Myalgia and arthralgia | 126 (71)* | 31 (18) | 20 (11) |
| Auriculoventricular heart block | 7 (5)* | 75 (50) | 69 (46) |
| Cranial neuritis | 21 (14)* | 68 (44) | 64 (42) |
| Recognized early signs and symptoms not related to early stage LD | |||
| Diarrhea | 55 (36)* | 18 (12) | 80 (52) |
Data presented as n (%).
*
Correct answer